Position in LLY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$413,803
+$91,884 QoQ
Shares Held
345
-1.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#3,913
of 4,605 holders
Holding Since
Jun 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GARRISON POINT ADVISORS, LLC holds $11,648,529 across 8 Drug Manufacturers - General names. LLY ranks #7 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
16,613 | $4,219,203 | |
| 2 | AMGN |
Amgen Inc
|
5,460 | $1,977,175 | |
| 3 | NVO |
Novo Nordisk A S
|
33,268 | $1,594,867 | |
| 4 | MRK |
Merck & Co., Inc.
|
12,116 | $1,556,906 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
15,198 | $875,708 | |
| 6 | ABBV |
AbbVie Inc.
|
3,016 | $758,946 | |
| 7 | LLY |
ELI LILLY & Co
This page
|
345 | $413,803 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,994 | $251,921 |
All Filings in LLY
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $413,803 | 345 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $321,919 | 350 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $451,365 | 420 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $328,090 | 430 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $436,536 | 560 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $462,509 | 560 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $331,960 | 430 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $380,954 | 430 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $389,313 | 430 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $373,420 | 480 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $279,801 | 480 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $273,936 | 510 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $248,559 | 530 | Shares | Sole | 2023-07-25 | |
| 2022-12-31 | $208,528 | 570 | Shares | Sole | 2023-02-01 | |
| 2022-06-30 | $207,507 | 640 | Shares | Sole | 2022-08-10 | |
| No filing history on record for this holder in this stock. | ||||||